 | | | | |
| |  | |  | | |
| |  |
| PRIME NEWS |  |
|
 |
|
|
The Food and Drug Administration has approved updated labeling for Abilify, a drug made jointly by Bristol-Myers Squibb and Japans Otsuka Pharmaceuticals
|
|
|
|
|
|
|
|
|
pSivida has begun clinical trial to assess the safety and efficacy of Medidur FA in conjunction with Lucentis in patients with exudative age-related macular degeneration (wet AMD)
|
|
|
|
|
|
|
 | | |
The latest pharmaceutical technology news, trends and analysis, pharma business and investment opportunities, pharmaceutical technology breakthroughs, launch and review of pharma, biopharma & pharmaceutical products, features, event listings and job postings.
| | | | |  | |  | | |
|
|
|
|
|
|
 |
|
 |
|
|
|
 |
FEATURES |
 |
|
|
|
The year that was! Round up 2007
|
|
| Year 2007 can easily be classified as the turning point for the life sciences industry. It saw the completion of the second phase of HapMap Projectcreated to identify and catalog genetic similarities and differences among populations around the world |
|
|
|
|
|
Vietnam pharma market opens up
|
|
| Vietnams entry into WTO in 2007 has boosted the fortunes of the local pharmaceutical industry and has created confidence among the MNC pharma companies and investors |
|
|
|
|
|
|
 |
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EVENTS |
|
|
|
|
Over 1200 firms attend API & INTERPHEX China
|
|
| The event attracted over 1200 domestic and oversees enterprises and over 30,000 professional visitors to Dalian, ranked as the 7th top Chinese cities in terms of competitive strength and supportive government authority |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
R & D |
|
|
|
|
|
|
Advinus achieves milestones in Merck collaboration
|
|
| Advinus Therapeutics, engaged in Pharmaceutical R&D headquartered in Bangalore, announced that it has achieved two more milestones, under the drug discovery and development collaboration between Advinus Therapeutics and Merck & Co |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PRODUCTS |
|
|
|
|
|
|
Lupin launches SUPRAX 400 in the US
|
|
| Lupin Pharmaceuticals, the wholly owned US subsidiary of Lupin Limited,, a leading Indian Pharmaceutical company has announced the launch of Suprax 400 mg Tablets in the US |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|  | |  | | | | |  | |  |
|
|
|
| | | | | | | | |
